The other signaling pathway in CML cells, which is mediated by binding of JAK2 to the SH2 domain of BCR-ABL1, leads to phosphorylation and activation of STAT3/5 [121]. This evidence concerns the gene JAK2 and chronic myelogenous leukemia, BCR-ABL1 positive.